Original Research
Published on 01 Jul 2025
Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P
in Cancer Immunity and Immunotherapy
- 232 views
Original Research
Published on 01 Jul 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 01 Jul 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 01 Jul 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 01 Jul 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 01 Jul 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 01 Jul 2025
in Cancer Immunity and Immunotherapy
Perspective
Published on 01 Jul 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 01 Jul 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 30 Jun 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 30 Jun 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 30 Jun 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 30 Jun 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 30 Jun 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 30 Jun 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 30 Jun 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 30 Jun 2025
in Cancer Immunity and Immunotherapy